Fluid component analysis system and method for glucose monitoring and control

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7972296
SERIAL NO

12249831

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed are methods and apparatus for determining analyte concentration in a sample such as bodily fluid. Systems and methods disclosed herein can also include a treatment dosing system to infuse or inject a treatment drug (e.g. insulin or glucose) and provide glycemic control. The dose of the treatment drug may be based on the concentration of the analyte or the average value for the concentration of the analyte and/or the rate of change of the value of the concentration of the analyte.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • OPTISCAN BIOMEDICAL CORPORATION

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Braig, James R Piedmont, US 160 10450
Keenan, Richard Livermore, US 66 2249
Rivas, Gil Danville, US 13 719
Rule, Peter Los Altos Hills, US 87 5575
Seetharaman, Mahesh Danville, US 9 508

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation